← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 1, 2015Last known activity
Sep 30, 2023
Timeline
2000s
- Jun 1, 2000
Molecular Templates— Founded
2010s
- Mar 17, 2017
Threshold Pharmaceuticals— Acquired
Drugs by trial phase (22 distinct, 41 trials)
Phase 3 (0 own, 5 via acquisition)
Phase 2 (2 own, 7 via acquisition)
Phase 1 (4 own, 4 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (12)
- NCT06034860OfficialPhase 1Sep 30, 2023
- NCT06034860Lead sponsorPhase 1Sep 30, 2023
- NCT04757090CollaboratorPhase 2Dec 31, 2021
- NCT04795713Lead sponsorPhase 1May 27, 2021
- NCT04029922Lead sponsorPhase 1Sep 30, 2019
- NCT03645395Lead sponsorPhase 2Dec 3, 2018
- NCT03488251Lead sponsorPhase 2Aug 20, 2018
- NCT02715843Lead sponsorN/ADec 1, 2015
- NCT02556346Lead sponsorPhase 1Nov 1, 2015
- NCT02556346Study directorPhase 1Nov 1, 2015
- NCT02361346Lead sponsorPhase 1Feb 1, 2015
- NCT02361346Study directorPhase 1Feb 1, 2015
Details
- Founded
- Georgetown, TX, US Jun 1, 2000
- Last known activity
- Sep 30, 2023